Kindstar Globalgene Declares Final 2025 Dividend of HKD 0.095 Per Share

Kindstar Globalgene Technology, Inc. ( (HK:9960) ) has shared an announcement.

Kindstar Globalgene Technology, Inc. has declared a final ordinary cash dividend of HKD 0.095 per share for the financial year ended 31 December 2025, payable in Hong Kong dollars. The dividend is subject to shareholder approval on 5 June 2026, with an ex-dividend date of 9 June 2026 and a payment date set for 27 August 2026.

The announcement outlines the key timetable for entitlement, including the book closure from 11 to 15 June 2026 and the record date of 15 June 2026, while confirming that no withholding tax or related warrant or convertible security issues apply. This payout signals management’s willingness to return capital to shareholders and may be read by investors as a sign of confidence in the company’s financial performance and cash generation for 2025.

The most recent analyst rating on (HK:9960) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Kindstar Globalgene Technology, Inc. stock, see the HK:9960 Stock Forecast page.

More about Kindstar Globalgene Technology, Inc.

Kindstar Globalgene Technology, Inc. is a Hong Kong-listed company operating in the healthcare and biotechnology sector, focusing on advanced genetic and molecular diagnostic services. The company targets patients, hospitals and healthcare providers seeking specialized testing solutions, positioning itself in a niche, technology-driven segment of the medical diagnostics market.

Average Trading Volume: 591,904

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.14B

For a thorough assessment of 9960 stock, go to TipRanks’ Stock Analysis page.